Co-existence of muscarinic and nicotinic receptors and their functional interaction in mouse Beta-TC6 cells

European Journal of Pharmacology

Volumn 604, Issue 1-3, 2009, Pages 150-157

  Ohtani, Masahiro ^a,b   Daly, John W ^a   Oka, Takami ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b MUSASHINO UNIVERSITY   (Japan)

Author keywords

Calcium; Carbamylcholine; Insulin secretion; Muscarinic receptor; Nicotine; Oxotremorine M

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CALCIUM; CARBACHOL; CHELERYTHRINE; INSULIN; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINE; NICOTINIC RECEPTOR; OXOTREMORINE M; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE C INHIBITOR;

ANIMAL CELL; ARTICLE; CALCIUM METABOLISM; CALCIUM TRANSPORT; CELL FUNCTION; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; INSULIN RELEASE; INSULINOMA; MEMBRANE POTENTIAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CELL LINE, TUMOR; CYTOPLASM; INSULIN; MICE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58949098280     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.12.018     Document Type: Article

References (34)

1. Boschero A.C., Szpak-Glasman M., Carneiro E.M., Bordin S., Paul I., Rojas E., and Atwater I. Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors. Am. J. Physiol. 268 (1995) 336-342
2. Cattaneo M.G., D'atri F., and Vicentini L.M. Mechanisms of mitogen-activated protein kinase activation by nicotine in small-cell lung carcinoma cells. Biochem. J. 328 (1997) 499-503
3. Cheng K., Zimniak P., and Raufman J.P. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. Cancer Res. 63 (2003) 6744-6750
4. Dajas-Bailador F., and Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signaling. Trends Pharmacol. Sci. 25 (2004) 317-324
5. Duttaroy A., Zimliki C.L., Gautam D., Cui Y., Mears D., and Wess J. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Diabetes 53 (2004) 1714-1720
6. Gautam D., Han S.J., Hamdan F.F., Jeon J., Li B., Li J.H., Cui Y., Mears D., Lu H., Deng C., Heard T., and Wess J. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab. 3 (2006) 449-461
7. Gilon P., and Henquin J.C. Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr. Rev. 22 (2001) 565-604
8. Gromada J., Høy M., Renström E., Bokvist K., Eliasson L., Göpel S., and Rorsman P. CaM kinase II-dependent mobilization of secretory granules underlies acetylcholine-induced stimulation of exocytosis in mouse pancreatic B-cells. J. Physiol. 518 (1999) 745-759
9. 2+ in clonal insulin-releasing cells. Evidence for an opposing effect of muscarinic-receptor activation. Biochem. J. 233 (1986) 865-870
10. 2+ stores in insulin-secreting HIT-T15 cells. Br. J. Pharmacol. 139 (2003) 351-361
11. Henquin J.C., and Nenquin M. The muscarinic receptor subtype in mouse pancreatic B-cells. FEBS Lett. 236 (1988) 89-92
12. Iismaa T.P., Kerr E.A., Wilson J.R., Carpenter L., Sims N., and Biden T.J. Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes 49 (2000) 392-398
13. Karlsson S., and Ahrén B. Muscarinic receptor subtypes in carbachol-stimulated insulin and glucagon secretion in the mouse. J. Auton. Pharmacol. 13 (1993) 439-446
14. Lambert D.G., and Atkins T.W. Cholinergic stimulation of insulin release from cloned B-cell lines HIT-T15 and RINm5F. Acta Diabetol. Lat. 26 (1989) 27-34
15. Lang F., Föller M., Lang K.S., Lang P.A., Ritter M., Gulbins E., Vereninov A., and Huber S.M. Ion channels in cell proliferation and apoptotic cell death. J. Membr. Biol. 205 (2005) 147-157
16. 2+. Diabetes 47 (1998) 1699-1706
17. Ohtani M., Oka T., Badyuk M., Xiao Y., Kellar K.J., and Daly J.W. Mouse β-TC6 insulinoma cells: high expression of functional α3β4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release. Mol. Pharmacol. 69 (2006) 899-907
18. Pei X.F., Gupta T.H., Badio B., Padgett W.L., and Daly J.W. 6Beta-acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors. J. Med. Chem. 41 (1998) 2047-2055
19. 2+ in carbamylcholine-stimulated insulinoma cells. J. Biol. Chem. 263 (1988) 11044-11047
20. Resende R.R., Alves A.S., Britto L.R., and Ulrich H. Role of acetylcholine receptors in proliferation and differentiation of P19 embryonal carcinoma cells. Exp. Cell Res. 314 (2008) 1429-1443
21. Resende R.R., Gomes K.N., Adhikari A., Britto L.R., and Ulrich H. Mechanism of acetylcholine-induced calcium signaling during neuronal differentiation of P19 embryonal carcinoma cells in vitro. Cell Calcium. 43 (2008) 107-121
22. Rojas E., Carrol P.B., Ricordi C., Boschero A.C., Stojilkovic S.S., and Atwater I. Control of cytosolic free calcium in cultured human pancreatic β-cells occurs by external calcium-dependent and independent mechanisms. Endocrinology 134 (1994) 1771-1781
23. Sun X., Liu Y., Hu G., and Wang H. Protective effects of nicotine against glutamate-induced neurotoxicity in PC12 cells. Cell Mol. Biol. Lett. 9 (2004) 409-422
24. Tang S.H., and Sharp G.W. Identification of muscarinic receptor subtypes in RINm5F cells by means of polymerase chain reaction, subcloning, and DNA sequencing. Diabetes 47 (1997) 1419-1423
25. Tang S.H., and Sharp G.W. Atypical protein kinase C isozyme zeta mediates carbachol-stimulated insulin secretion in RINm5F cells. Diabetes 47 (1998) 905-912
26. 2+ influx in insulin-secreting cells. J. Biol. Chem. 279 (2004) 19396-19400
27. Winzell M.S., and Ahrén B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol. Ther. 116 (2007) 437-448
28. Wollheim C.B., and Biden T.J. Second messenger function of inositol 1,4,5-triphosphate. J. Biol. Chem. 261 (1986) 8314-8319
29. 2+ concentration. J. Biol. Chem. 264 (1989) 2455-2462
30. Yamatani T., Chiba T., Kadowaki S., Hishikawa R., Yamaguchi A., Inui T., Fujita T., and Kawazu S. Dual action of protein kinase C activation in the regulation of insulin release by muscarinic agonist from rat insulinoma cell line (RINr). Endocrinology 122 (1988) 2826-2832
31. Yoshikawa H., Hellström-Lindahl E., and Grill V. Evidence for functional nicotinic receptors on pancreatic beta cells. Metabolism 54 (2005) 247-254
32. Zawalich W.S., Zawalich K.C., Tesz G.J., Taketo M.M., Sterpka J., Philbrick W., and Matsui M. Effects of muscarinic receptor type 3 knockout on mouse islet secretory responses. Biochem. Biophys. Res. Commun. 315 (2004) 872-876
33. Zhou C., Wen Z.X., Shi D.M., and Xie Z.P. Muscarinic acetylcholine receptors involved in the regulation of neural stem cell proliferation and differentiation in vitro. Cell Biol. Int. 28 (2004) 63-67
34. Zhou W., Zhu X., Zhu L., Cui Y.Y., Wang H., Qi H., Ren Q.S., and Chen H.Z. Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons. Cell Mol. Neurobiol. 28 (2008) 263-275